Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nature ; 496(7444): 238-42, 2013 Apr 11.
Article in English | MEDLINE | ID: mdl-23535595

ABSTRACT

Macrophages activated by the Gram-negative bacterial product lipopolysaccharide switch their core metabolism from oxidative phosphorylation to glycolysis. Here we show that inhibition of glycolysis with 2-deoxyglucose suppresses lipopolysaccharide-induced interleukin-1ß but not tumour-necrosis factor-α in mouse macrophages. A comprehensive metabolic map of lipopolysaccharide-activated macrophages shows upregulation of glycolytic and downregulation of mitochondrial genes, which correlates directly with the expression profiles of altered metabolites. Lipopolysaccharide strongly increases the levels of the tricarboxylic-acid cycle intermediate succinate. Glutamine-dependent anerplerosis is the principal source of succinate, although the 'GABA (γ-aminobutyric acid) shunt' pathway also has a role. Lipopolysaccharide-induced succinate stabilizes hypoxia-inducible factor-1α, an effect that is inhibited by 2-deoxyglucose, with interleukin-1ß as an important target. Lipopolysaccharide also increases succinylation of several proteins. We therefore identify succinate as a metabolite in innate immune signalling, which enhances interleukin-1ß production during inflammation.


Subject(s)
Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Interleukin-1beta/biosynthesis , Signal Transduction , Succinic Acid/metabolism , Animals , Bone Marrow Cells/cytology , Citric Acid Cycle/drug effects , Deoxyglucose/pharmacology , Down-Regulation/drug effects , Genes, Mitochondrial/drug effects , Genes, Mitochondrial/genetics , Glutamine/metabolism , Glycolysis/drug effects , Glycolysis/genetics , Humans , Immunity, Innate/drug effects , Inflammation/metabolism , Interleukin-1beta/genetics , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Mice , Up-Regulation/drug effects , gamma-Aminobutyric Acid/metabolism
2.
J Am Optom Assoc ; 61(11): 820-6, 1990 Nov.
Article in English | MEDLINE | ID: mdl-2081823

ABSTRACT

Monovision has been a controversial contact lens correction modality for over 30 years. This paper addresses the major issues and concerns and considers them in the light of patient safety, visual efficiency and practitioner liability.


Subject(s)
Vision, Monocular/physiology , Adaptation, Ocular/physiology , Automobile Driving , Contact Lenses , Contrast Sensitivity/physiology , Depth Perception/physiology , Eyeglasses , Humans , Motion Perception/physiology , Presbyopia/therapy , Vision Disparity/physiology , Vision Screening , Vision, Binocular/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...